Heart Valve Devices | Market Insights | Europe | 2021
The European heart valve devices market will grow through 2029, fueled by the rapid adoption of THV devices and an aging population. Clinical investigations continue to generate positive results and propel the THV market forward; large companies, in particular, are vying to secure and expand their market share by launching clinical trials and targeting small companies with innovative devices for acquisition to add new, cutting-edge THV devices to their portfolios. Furthermore, novel devices and device types will continue to emerge in the coming years and access new patient populations, generating continued growth in this market. However, the COVID-19 global pandemic will have a significant impact on the European heart valve devices market, resulting in lost procedure volumes in the short term followed by a period of recovery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Europe across a 10-year period.
